FHI Clinical Providing Full-Service CRO Capabilities for Coronavirus (COVID-19) Clinical Trial

FHI Clinical Inc. announces today it has partnered with Infectious Disease Research Institute (IDRI) , a Seattle-based not-for-profit organization, to provide full-service contract research organization (CRO) capabilities for an immunotherapy clinical trial to combat moderate to severe cases of COVID-19.